Technical Analysis for BIOR - Biora Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.74 | 2.77% | 0.02 |
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 2.75% | |
| Upper Bollinger Band Walk | Strength | 2.75% | |
| Weak + Overbought | Other | 2.75% | |
| Overbought Stochastic | Strength | 2.75% | |
| Bearish Engulfing | Bearish | -0.62% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.62% | |
| Narrow Range Bar | Range Contraction | -0.62% | |
| Upper Bollinger Band Walk | Strength | -0.62% | |
| Weak + Overbought | Other | -0.62% | |
| Inside Day | Range Contraction | -0.62% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 2 hours ago |
| Rose Above Previous Day's High | about 2 hours ago |
| Up 3% | about 2 hours ago |
| Up 2% | about 3 hours ago |
| Up 1% | about 3 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/13/2024
Biora Therapeutics, Inc. Description
Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Disease Genomics Drug Delivery In Vitro Precision Medicine Proteomics Systems Biology Systems Science
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.6996 |
| 52 Week Low | 0.585 |
| Average Volume | 460,026 |
| 200-Day Moving Average | 1.65 |
| 50-Day Moving Average | 0.90 |
| 20-Day Moving Average | 0.66 |
| 10-Day Moving Average | 0.68 |
| Average True Range | 0.06 |
| RSI (14) | 47.37 |
| ADX | 21.84 |
| +DI | 23.89 |
| -DI | 21.68 |
| Chandelier Exit (Long, 3 ATRs) | 0.59 |
| Chandelier Exit (Short, 3 ATRs) | 0.76 |
| Upper Bollinger Bands | 0.75 |
| Lower Bollinger Band | 0.56 |
| Percent B (%b) | 0.8 |
| BandWidth | 29.64 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.07 |
| MACD Histogram | 0.0289 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.77 | ||||
| Resistance 3 (R3) | 0.77 | 0.76 | 0.76 | ||
| Resistance 2 (R2) | 0.76 | 0.75 | 0.76 | 0.76 | |
| Resistance 1 (R1) | 0.74 | 0.74 | 0.73 | 0.73 | 0.75 |
| Pivot Point | 0.73 | 0.73 | 0.72 | 0.72 | 0.73 |
| Support 1 (S1) | 0.70 | 0.71 | 0.70 | 0.70 | 0.68 |
| Support 2 (S2) | 0.69 | 0.71 | 0.69 | 0.68 | |
| Support 3 (S3) | 0.67 | 0.69 | 0.67 | ||
| Support 4 (S4) | 0.66 |
